Ondansetron

NDC 51655-196 · Northwind Health Company, LLC

Generic nameOndansetron

Dosage formTABLET, ORALLY DISINTEGRATING

RouteORAL

Active ingredient(s)ONDANSETRON

Strength8 mg/1

Pharmacologic classSerotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

51655-196-04 — 4 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-04)

51655-196-53 — 10 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-53)

51655-196-80 — 8 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-80)

51655-196-87 — 6 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-87)

FDA lists these products with the same active ingredient.

43063-857 — Ondansetron, 43063-870 — Ondansetron, 50090-1128 — Ondansetron, 50090-1200 — Ondansetron, 50090-1201 — Ondansetron, 50090-1658 — Ondansetron, 50090-1659 — Ondansetron, 50090-2343 — Ondansetron, 50090-4632 — Ondansetron, 51655-008 — Ondansetron, 51655-809 — Ondansetron, 51655-913 — Ondansetron, 51662-1246 — ONDANSETRON, 51662-1514 — ONDANSETRON, 55154-3680 — Ondansetron, 55154-4567 — ondansetron, 55154-8339 — Ondansetron, 57237-077 — Ondansetron, 57237-078 — Ondansetron, 60760-306 — Ondansetron, +78 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.